Skip to main content

Table 5 Regression coefficients (β), R-squared values and p-values from linear regression analysis

From: Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study

Dependent variable Independent variable Placebo Liraglutide
β R2 p-value β R2 p-value
ΔAverage eʹ Δheart rate − 0.012 0.010 0.602 − 0.016 0.033 0.339
ΔAverage eʹ Δweight 0.054 0.022 0.437 < 0.001 < 0.001 0.993
ΔAverage eʹ ΔHbA1C − 0.010 < 0.001 0.981 0.147 0.003 0.783
ΔAverage eʹ ΔSystolic BP 0.006 0.010 0.603 0.002 0.001 0.882
ΔAverage eʹ ΔDiastolic BP − 0.010 0.008 0.639 − 0.023 0.081 0.127
Lateral eʹ velocity Δheart rate < 0.001 < 0.001 0.993 − 0.002 < 0.001 0.930
Lateral eʹ velocity Δweight 0.008 < 0.001 0.944 − 0.040 0.012 0.572
Lateral eʹ velocity ΔHbA1C − 0.002 < 0.001 0.997 0.126 0.001 0.861
Lateral eʹ velocity ΔSystolic BP 0.014 0.020 0.459 − 0.014 0.036 0.319
Lateral eʹ velocity ΔDiastolic BP − 0.016 0.009 0.628 − 0.026 0.061 0.189
Septal eʹ velocity Δheart rate − 0.029 0.044 0.277 − 0.023 0.070 0.167
Septal eʹ velocity Δweight 0.111 0.074 0.154 0.021 0.006 0.685
Septal eʹ velocity ΔHbA1C 0.084 0.001 0.857 0.452 0.028 0.388
Septal eʹ velocity ΔSystolic BP 0.000 < 0.001 0.983 − 0.007 0.018 0.489
Septal eʹ velocity ΔDiastolic BP − 0.015 0.017 0.502 − 0.025 0.107 0.084
Average E/eʹ Δheart rate − 0.063 0.023 0.423 − 0.061 0.054 0.225
Average E/eʹ Δweight 0.118 0.008 0.631 0.241 0.107 0.083
Average E/eʹ ΔHbA1C 2.889 0.135 0.046 − 1.072 0.020 0.461
Average E/eʹ ΔSystolic BP − 0.008 0.002 0.836 − 0.010 0.004 0.735
Average E/eʹ ΔDiastolic BP − 0.045 0.014 0.539 0.055 0.064 0.185
  1. HbA1C glycated hemoglobin, BP blood pressure